{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:40:32Z","timestamp":1792788032310,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T00:00:00Z","timestamp":1791504000000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Outstanding Young Investigator Fund of Sichuan Cancer Hospital","award":["YB2026025"],"award-info":[{"award-number":["YB2026025"]}],"id":[{"id":"https:\/\/ror.org\/029wq9x81","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Science and Technology Department of Sichuan Province","award":["24ZDYF0363"],"award-info":[{"award-number":["24ZDYF0363"]}],"id":[{"id":"https:\/\/ror.org\/04323m874","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Key Research and Development Program of the Chengdu Science and Technology Bureau","award":["2024-YF05-01147-SN"],"award-info":[{"award-number":["2024-YF05-01147-SN"]}],"id":[{"id":"https:\/\/ror.org\/00xfea068","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"DOI":"10.1186\/s13014-026-02886-x","type":"journal-article","created":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:36:23Z","timestamp":1784100983000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Postoperative adjuvant therapy for pT3N0M0 esophageal carcinoma: does radiotherapy offer added benefit beyond chemotherapy?"],"prefix":"10.1186","volume":"21","author":[{"given":"Tian","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruixia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunxiang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,15]]},"reference":[{"key":"2886_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han B, Zheng R, Zeng H, Wang S, Sun K, Chen R, et al. Cancer incidence and mortality in China, 2022. J Natl Cancer Cent. 2024;4:47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006.","journal-title":"J Natl Cancer Cent"},{"key":"2886_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-018-0346-4","volume":"39","author":"X Guan","year":"2019","unstructured":"Guan X, Ma F, Li C, Wu S, Hu S, Huang J, et al. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial\u2013mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer. Cancer Commun. 2019;39:1. https:\/\/doi.org\/10.1186\/s40880-018-0346-4.","journal-title":"Cancer Commun"},{"key":"2886_CR3","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2018.06.65","author":"T Liu","year":"2018","unstructured":"Liu T, Liu W, Zhang H, Ren C, Chen J, Dang J. The role of postoperative radiotherapy for radically resected esophageal squamous cell carcinoma: A systemic review and meta-analysis. J Thorac Dis [Internet] AME. 2018. https:\/\/doi.org\/10.21037\/jtd.2018.06.65. [cited 2025 Feb 10];10. Publishing Company.","journal-title":"J Thorac Dis [Internet] AME"},{"key":"2886_CR4","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1245\/s10434-020-09206-x","volume":"28","author":"A Wakita","year":"2021","unstructured":"Wakita A, Motoyama S, Sato Y, Nagaki Y, Fujita H, Terata K, et al. Verification of the optimal interval before esophagectomy after preoperative neoadjuvant chemoradiotherapy for locally advanced thoracic esophageal cancer. Ann Surg Oncol. 2021;28:2101\u201310. https:\/\/doi.org\/10.1245\/s10434-020-09206-x.","journal-title":"Ann Surg Oncol"},{"key":"2886_CR5","doi-asserted-by":"publisher","first-page":"830","DOI":"10.6004\/jnccn.2011.0072","volume":"9","author":"JA Ajani","year":"2011","unstructured":"Ajani JA, Barthel JS, Bentrem DJ, D\u2019Amico TA, Das P, Denlinger CS, et al. Esophageal and esophagogastric junction cancers. J Natl Compr Canc Netw. 2011;9:830\u201387. https:\/\/doi.org\/10.6004\/jnccn.2011.0072.","journal-title":"J Natl Compr Canc Netw"},{"key":"2886_CR6","doi-asserted-by":"publisher","first-page":"doae026","DOI":"10.1093\/dote\/doae026","volume":"37","author":"S Pei","year":"2024","unstructured":"Pei S, Huang J-Q, Liang H-W, Liu Y, Chen L, Yu B-B, et al. Adjuvant treatment patterns for pT3N0M0 esophageal cancer undergoing surgery. Dis Esophagus. 2024;37:doae026. https:\/\/doi.org\/10.1093\/dote\/doae026.","journal-title":"Dis Esophagus"},{"key":"2886_CR7","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1245\/s10434-019-08112-1","volume":"27","author":"Q Wang","year":"2020","unstructured":"Wang Q, Peng L, Li T, Dai W, Jiang Y, Xie T, et al. Postoperative chemotherapy for thoracic pathological T3N0M0 esophageal squamous cell carcinoma. Ann Surg Oncol. 2020;27:1488\u201395. https:\/\/doi.org\/10.1245\/s10434-019-08112-1.","journal-title":"Ann Surg Oncol"},{"key":"2886_CR8","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1200\/JCO.2003.12.095","volume":"21","author":"N Ando","year":"2003","unstructured":"Ando N, Iizuka T, Ide H, Ishida K, Shinoda M, Nishimaki T, et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A japan clinical oncology group study\u2014JCOG9204. J Clin Oncol. 2003;21:4592\u20136. https:\/\/doi.org\/10.1200\/JCO.2003.12.095.","journal-title":"J Clin Oncol"},{"key":"2886_CR9","doi-asserted-by":"publisher","first-page":"959568","DOI":"10.3389\/fsurg.2022.959568","volume":"9","author":"C Song","year":"2022","unstructured":"Song C, Zhu S, Xu J, Su J, Zhang X, Deng W, et al. Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancer. Front Surg. 2022;9:959568. https:\/\/doi.org\/10.3389\/fsurg.2022.959568.","journal-title":"Front Surg"},{"key":"2886_CR10","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13014-024-02528-0","volume":"19","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, Su X, Zhou T, Jia J, Liu J, Yu W, et al. Propensity-matched study on locally advanced esophageal cancer: Surgery versus post-operative radiotherapy. Radiat Oncol. 2024;19:130. https:\/\/doi.org\/10.1186\/s13014-024-02528-0.","journal-title":"Radiat Oncol"},{"key":"2886_CR11","doi-asserted-by":"publisher","unstructured":"Gao H, Wang Y, Jiang Z, Shi G, Hu S, Ai J, et al. Association of survival with adjuvant radiotherapy for pN0 esophageal cancer. Aging. 2023;3158\u201370. https:\/\/doi.org\/10.18632\/aging.204677.","DOI":"10.18632\/aging.204677"},{"key":"2886_CR12","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00432-015-2041-z","volume":"142","author":"S Chen","year":"2016","unstructured":"Chen S, Weng H, Wang G, Liu D, Li H, Zhang H, et al. The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma. J Cancer Res Clin Oncol. 2016;142:277\u201386. https:\/\/doi.org\/10.1007\/s00432-015-2041-z.","journal-title":"J Cancer Res Clin Oncol"},{"key":"2886_CR13","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jtcvs.2018.10.057","volume":"157","author":"SM Atay","year":"2019","unstructured":"Atay SM, Correa A, Hofstetter WL, Swisher SG, Ajani J, Altorki NK, et al. Predictors of staging accuracy, pathologic nodal involvement, and overall survival for cT2N0 carcinoma of the esophagus. J Thorac Cardiovasc Surg. 2019;157:1264\u2013e12726. https:\/\/doi.org\/10.1016\/j.jtcvs.2018.10.057.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"Suppl 1","key":"2886_CR14","doi-asserted-by":"publisher","first-page":"C16","DOI":"10.4103\/0973-1482.163833","volume":"11","author":"Y Wang","year":"2015","unstructured":"Wang Y, Wang L, Yang Q, Li J, Qi Z, He M, et al. Factors on prognosis in patients of stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy. J Cancer Res Ther. 2015;11(Suppl 1):C16\u201323. https:\/\/doi.org\/10.4103\/0973-1482.163833.","journal-title":"J Cancer Res Ther"},{"key":"2886_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10388-015-0515-3","volume":"13","author":"Y Tachimori","year":"2016","unstructured":"Tachimori Y, Ozawa S, Numasaki H, Hisahiro Matsubara, Shinoda M, Toh Y, et al. Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus Off J Jpn Esophageal Soc. 2016;13:1\u20137. https:\/\/doi.org\/10.1007\/s10388-015-0515-3.","journal-title":"Esophagus Off J Jpn Esophageal Soc"},{"key":"2886_CR16","doi-asserted-by":"publisher","first-page":"S724","DOI":"10.21037\/jtd.2017.06.19","volume":"9","author":"Y Tachimori","year":"2017","unstructured":"Tachimori Y. Pattern of lymph node metastases of squamous cell esophageal cancer based on the anatomical lymphatic drainage system: Efficacy of lymph node dissection according to tumor location. J Thorac Dis. 2017;9:S724\u201330. https:\/\/doi.org\/10.21037\/jtd.2017.06.19.","journal-title":"J Thorac Dis"},{"key":"2886_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12957-021-02412-1","volume":"19","author":"Y Wang","year":"2021","unstructured":"Wang Y, Xiao P, Yang N, Wang X, Ma K, Wu L, et al. Unresected small lymph node assessment predicts prognosis for patients with pT3N0M0 thoracic esophageal squamous cell carcinoma. World J Surg Oncol. 2021;19:303\u201315. https:\/\/doi.org\/10.1186\/s12957-021-02412-1.","journal-title":"World J Surg Oncol"},{"key":"2886_CR18","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1097\/AS9.0000000000000497","volume":"5","author":"S Raja","year":"2024","unstructured":"Raja S, Rice TW, Lu M, Semple ME, Toth AJ, Blackstone EH, et al. Adjuvant therapy after esophagectomy for esophageal cancer: Who needs it? multi-institution worldwide observational study. Ann Surg Open. 2024;5:e497. https:\/\/doi.org\/10.1097\/AS9.0000000000000497.","journal-title":"Ann Surg Open"},{"key":"2886_CR19","doi-asserted-by":"publisher","first-page":"1181505","DOI":"10.3389\/fsurg.2023.1181505","volume":"10","author":"S Chen","year":"2023","unstructured":"Chen S, Liu D, Chen Y. Impact of adjuvant chemotherapy for radically resected esophageal squamous cell carcinoma: A propensity score matching analysis. Front Surg. 2023;10:1181505. https:\/\/doi.org\/10.3389\/fsurg.2023.1181505.","journal-title":"Front Surg"},{"key":"2886_CR20","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.4251\/wjgo.v11.i12.1172","volume":"11","author":"Y Zeng","year":"2019","unstructured":"Zeng Y, Yu W, Liu Q, Yu W-W, Zhu Z-F, Zhao W-X, et al. Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy. World J Gastrointest Oncol. 2019;11:1172\u201381. https:\/\/doi.org\/10.4251\/wjgo.v11.i12.1172.","journal-title":"World J Gastrointest Oncol"},{"key":"2886_CR21","doi-asserted-by":"publisher","first-page":"oyaf315","DOI":"10.1093\/oncolo\/oyaf315","volume":"30","author":"J Peng","year":"2025","unstructured":"Peng J, Wang Y, Hu H, Wu L, Dai W, Zhou Y, et al. Lymph node ratio predicts adjuvant chemotherapy benefit in esophageal squamous cell carcinoma. Oncologist. 2025;30:oyaf315. https:\/\/doi.org\/10.1093\/oncolo\/oyaf315.","journal-title":"Oncologist"},{"key":"2886_CR22","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.jtho.2017.03.024","volume":"12","author":"J Yang","year":"2017","unstructured":"Yang J, Zhang W, Xiao Z, Wang Q, Zhou Z, Zhang H, et al. The impact of postoperative conformal radiotherapy after radical surgery on survival and recurrence in pathologic T3N0M0 esophageal carcinoma: A propensity score-matched analysis. J Thorac Oncol. 2017;12:1143\u201351. https:\/\/doi.org\/10.1016\/j.jtho.2017.03.024.","journal-title":"J Thorac Oncol"},{"key":"2886_CR23","doi-asserted-by":"publisher","first-page":"e701","DOI":"10.1634\/theoncologist.2019-0276","volume":"25","author":"W Deng","year":"2020","unstructured":"Deng W, Yang J, Ni W, Li C, Chang X, Han W, et al. Postoperative radiotherapy in pathological T2\u20133N0M0 thoracic esophageal squamous cell carcinoma: Interim report of a prospective, phase III, randomized controlled study. Oncologist. 2020;25:e701\u20138. https:\/\/doi.org\/10.1634\/theoncologist.2019-0276.","journal-title":"Oncologist"},{"key":"2886_CR24","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.2217\/fon-2020-1084","volume":"17","author":"X Gu","year":"2021","unstructured":"Gu X, Ge Y, Liu J, Ding Q, Chu J, Tian G, et al. Impact of chemotherapy on prognosis of resectable pathological T3N0M0 esophageal cancer patients: a population-based study. Future Oncol Lond Engl. 2021;17:3925\u201340. https:\/\/doi.org\/10.2217\/fon-2020-1084.","journal-title":"Future Oncol Lond Engl"},{"key":"2886_CR25","doi-asserted-by":"publisher","first-page":"030006052097740","DOI":"10.1177\/0300060520977403","volume":"48","author":"W Feng","year":"2020","unstructured":"Feng W, Qi Z, Qiu R, Li Z-S, Dong S-L, Li Y-K, et al. Risk factors for tumor recurrence in patients with pT3N0M0 thoracic esophageal squamous cell carcinoma after esophagectomy. J Int Med Res SAGE Publications Ltd. 2020;48:0300060520977403. https:\/\/doi.org\/10.1177\/0300060520977403.","journal-title":"J Int Med Res SAGE Publications Ltd"},{"key":"2886_CR26","doi-asserted-by":"publisher","first-page":"49","DOI":"10.51666\/fs.2023.3.e5","volume":"3","author":"DG Shin","year":"2023","unstructured":"Shin DG. Patterns of lymph node metastasis in esophageal carcinoma and their importance in esophageal cancer treatment. Foregut Surg. 2023;3:49\u201358. https:\/\/doi.org\/10.51666\/fs.2023.3.e5.","journal-title":"Foregut Surg"},{"key":"2886_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.652365","author":"T Cui","year":"2021","unstructured":"Cui T, Zhang H, Yu T, Chen Y, Liu C, Zhao Q, et al. Pattern of recurrence in 428 patients with thoracic esophageal squamous cell carcinoma after radical surgery and its implication in postoperative radiotherapeutic clinical target volume. Front Oncol [Internet] Front. 2021. https:\/\/doi.org\/10.3389\/fonc.2021.652365. [cited 2026 June 21];11.","journal-title":"Front Oncol [Internet] Front"},{"key":"2886_CR28","doi-asserted-by":"publisher","first-page":"S1193","DOI":"10.1016\/j.annonc.2020.08.2299","volume":"31","author":"RJ Kelly","year":"2020","unstructured":"Kelly RJ, Ajani JA, Kuzdzal J, Zander T, Van Cutsem E, Piessen G, et al. LBA9_PR adjuvant nivolumab in resected esophageal or gastroesophageal junction cancer (EC\/GEJC) following neoadjuvant chemoradiation therapy (CRT): First results of the CheckMate 577 study. Ann Oncol. 2020;31:S1193\u20134. https:\/\/doi.org\/10.1016\/j.annonc.2020.08.2299.","journal-title":"Ann Oncol"},{"key":"2886_CR29","doi-asserted-by":"publisher","DOI":"10.4251\/wjgo.v17.i8.108484","author":"L-Y Li","year":"2025","unstructured":"Li L-Y, Zhang M-Q, Ying W-M, Zhang W-Z, Jiang W-J, Xiong T-J, et al. Postoperative adjuvant PD-1 immunotherapy survival and body-mass-index dynamics in esophageal cancer: A real-world retrospective study. World J Gastrointest Oncol [Internet]. 2025. https:\/\/doi.org\/10.4251\/wjgo.v17.i8.108484. [cited 2025 Aug 31];17.","journal-title":"World J Gastrointest Oncol [Internet]"},{"key":"2886_CR30","doi-asserted-by":"publisher","unstructured":"Xiong J, Lu S, Liang S, Chen H, Wang Z, Meng H et al. Impact of perineural invasion in thoracic esophageal squamous cell carcinoma\u2014a retrospective study with long-term follow-up outcomes. J Thorac Dis [Internet]. AME Publishing Company, 2025 [cited 2026 June 20];17(5):2989-3003. https:\/\/doi.org\/10.21037\/jtd-2024-2043.","DOI":"10.21037\/jtd-2024-2043"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-026-02886-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02886-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-026-02886-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:45:46Z","timestamp":1791503146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13014-026-02886-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,15]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2886"],"URL":"https:\/\/doi.org\/10.1186\/s13014-026-02886-x","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,15]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The study was approved by the ethics committee of Sichuan Cancer Hospital. (ethical approval number SCCHEC-02\u20132023-029) and the requirement for informed consent was waived due to the retrospective nature of the study.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"137"}}